APA (7th ed.) Citation

Kgokolo, M. C., Malinga, N. Z., Steel, H. C., Meyer, P. W., Smit, T., Anderson, R., & Rapoport, B. L. (2024). Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma. Translational oncology, 42, 101867. https://doi.org/10.1016/j.tranon.2023.101867

Chicago Style (17th ed.) Citation

Kgokolo, Mahlatse C.M., Nonkululeko Z. Malinga, Helen C. Steel, Pieter W.A Meyer, Teresa Smit, Ronald Anderson, and Bernardo L. Rapoport. "Transforming Growth Factor-β1 and Soluble Co-inhibitory Immune Checkpoints as Putative Drivers of Immune Suppression in Patients with Basal Cell Carcinoma." Translational Oncology 42 (2024): 101867. https://doi.org/10.1016/j.tranon.2023.101867.

MLA (9th ed.) Citation

Kgokolo, Mahlatse C.M., et al. "Transforming Growth Factor-β1 and Soluble Co-inhibitory Immune Checkpoints as Putative Drivers of Immune Suppression in Patients with Basal Cell Carcinoma." Translational Oncology, vol. 42, 2024, p. 101867, https://doi.org/10.1016/j.tranon.2023.101867.